Skip to main content
. Author manuscript; available in PMC: 2023 Dec 1.
Published in final edited form as: Ophthalmology. 2022 Jul 12;129(12):1344–1356. doi: 10.1016/j.ophtha.2022.07.003

Table 6.

Visual Acuity Results in the PTVT Study

Tube Group Trabeculectomy Group P-value
ETDRS VA, mean ± SD
 Baseline 73 ± 20 73 ± 20 0.96
 5 years 69 ± 23 66 ± 27 0.50
 Change* −6 ± 17 −11 ± 21 0.13

Snellen VA, logMAR mean ± SD
 Baseline 0.20 ± 0.42 0.25 ± 0.51 0.42
 5 years 0.30 ± 0.54 0.42 ± 0.81 0.24
 Change* 0.16 ± 0.37 0.21 ± 0.52 0.43

Loss of ≥ 2 Snellen lines, n (%) 31 (32) 29 (31) 1.00§
 Glaucoma 9 9
 Cataract 8 8
 Macular disease 5 4
 Other 2 5
 Unknown 9 3

ETDRS = Early Treatment Diabetic Retinopathy Study; SD = standard deviation; VA = visual acuity

*

Not all patients seen at baseline returned for 5-year visits, so the baseline mean minus the 5-year mean does not equal the change

Some patients had more than 1 reason for decreased vision

Student t-test

§

Chi-square test